<DOC>
	<DOCNO>NCT01968395</DOCNO>
	<brief_summary>The objective study conduct population pharmacokinetic analysis caspofungin population patient moderate severe acute alcoholic hepatitis liver disease Child-Pugh score B C order well characterize pharmacokinetic parameter case moderate severe liver dysfunction .</brief_summary>
	<brief_title>Pharmacokinetics Caspofungin After One Dose Patients With Liver Failure</brief_title>
	<detailed_description>patient admit alcoholic hepatitis decompensated cirrhosis Child-Pugh score 7-9 10-15 include ; patient without invasive aspergillosis .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Liver failure ChildPugh B C Cachexia ( BMI &lt; 15 kg/mÂ² ) Pregnancy HIV Hepatitis C patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>